These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963 [TBL] [Abstract][Full Text] [Related]
8. Design of Ru-arene Complexes for Antitumor Drugs. Su W; Li Y; Li P Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728 [TBL] [Abstract][Full Text] [Related]
9. Dinuclear Organoruthenium Complexes Exhibiting Antiproliferative Activity through DNA Damage and a Reactive-Oxygen-Species-Mediated Endoplasmic Reticulum Stress Pathway. Zhao J; Li S; Wang X; Xu G; Gou S Inorg Chem; 2019 Feb; 58(3):2208-2217. PubMed ID: 30675781 [TBL] [Abstract][Full Text] [Related]
10. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling. Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes. Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289 [TBL] [Abstract][Full Text] [Related]
12. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands. Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875 [TBL] [Abstract][Full Text] [Related]
13. Two new Cu(II) dipeptide complexes based on 5-methyl-2-(2'-pyridyl)benzimidazole as potential antimicrobial and anticancer drugs: Special exploration of their possible anticancer mechanism. Qi YY; Gan Q; Liu YX; Xiong YH; Mao ZW; Le XY Eur J Med Chem; 2018 Jun; 154():220-232. PubMed ID: 29803995 [TBL] [Abstract][Full Text] [Related]
14. Lipophilicity-antiproliferative activity relationship study leads to the preparation of a ruthenium(II) arene complex with considerable in vitro cytotoxicity against cancer cells and a lower in vivo toxicity in zebrafish embryos than clinically approved cis-platin. Haghdoost M; Golbaghi G; Létourneau M; Patten SA; Castonguay A Eur J Med Chem; 2017 May; 132():282-293. PubMed ID: 28371640 [TBL] [Abstract][Full Text] [Related]
15. Activation by Oxidation: Ferrocene-Functionalized Ru(II)-Arene Complexes with Anticancer, Antibacterial, and Antioxidant Properties. Mu C; Prosser KE; Harrypersad S; MacNeil GA; Panchmatia R; Thompson JR; Sinha S; Warren JJ; Walsby CJ Inorg Chem; 2018 Dec; 57(24):15247-15261. PubMed ID: 30495936 [TBL] [Abstract][Full Text] [Related]
16. Organometallic ruthenium(II)-arene complexes with triphenylphosphine amino acid bioconjugates: Synthesis, characterization and biological properties. Pernar M; Kokan Z; Kralj J; Glasovac Z; Tumir LM; Piantanida I; Eljuga D; Turel I; Brozovic A; Kirin SI Bioorg Chem; 2019 Jun; 87():432-446. PubMed ID: 30925428 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents. Lucas SJ; Lord RM; Wilson RL; Phillips RM; Sridharan V; McGowan PC Dalton Trans; 2012 Dec; 41(45):13800-2. PubMed ID: 23015068 [TBL] [Abstract][Full Text] [Related]
18. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells. Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087 [TBL] [Abstract][Full Text] [Related]
19. Ruthenium-Arene-β-Carboline Complexes as Potent Inhibitors of Cyclin-Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies. He L; Liao SY; Tan CP; Ye RR; Xu YW; Zhao M; Ji LN; Mao ZW Chemistry; 2013 Sep; 19(36):12152-60. PubMed ID: 23878093 [TBL] [Abstract][Full Text] [Related]